Insider · CIK 0001855608

Valantine Hannah

Reports to the SEC for 3 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001855608

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-16	CDNACareDx, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,606 sh	$20.56	+$156K	44,292
2026-07-16	CDNACareDx, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16K sh	$14.19	+$228K	60,340
2026-07-16	CDNACareDx, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,125 sh	$7.96	+$40.8K	65,465
2026-07-16	CDNACareDx, Inc.S Sale	Director	SSale	−28.7K sh	$36.14	−$1.04M	36,786
2026-07-16	CDNACareDx, Inc.S Sale	Director	SSale	−100 sh	$36.55	−$3,655	36,686
2026-07-16	CDNACareDx, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,606 sh	—	—	0
2026-07-16	CDNACareDx, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−16K sh	—	—	0
2026-07-16	CDNACareDx, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,125 sh	—	—	24,011
2026-06-23	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−2,196 sh	$68.57	−$151K	9,259
2026-06-22	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+3,990 sh	—	—	11,455
2026-06-22	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,808 sh	$41.73	+$117K	14,263
2026-06-22	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−2,808 sh	$68.00	−$191K	11,455
2026-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,277 sh	—	—	5,277
2026-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,808 sh	—	—	5,617
2026-06-15	CDNACareDx, Inc.S Sale	Director	SSale	−12.1K sh	$23.11	−$280K	36,686
2026-06-12	CDNACareDx, Inc.A Award	Director	AAward	+9,795 sh	—	—	48,789
2026-06-03	PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Stock Option (right to buy)A Award	Director	AAward	+223K sh	—	—	223,492
2026-03-10	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,671 sh	$27.36	+$237K	16,136
2026-03-10	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−8,671 sh	$72.00	−$624K	7,465
2026-03-10	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,671 sh	—	—	17,343
2026-02-27	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25.5K sh	$48.45	+$1.23M	32,949
2026-02-27	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−14.6K sh	$67.08	−$978K	18,365
2026-02-27	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−10.9K sh	$67.84	−$739K	7,465
2026-02-27	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25.5K sh	—	—	0
2025-11-12	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25.5K sh	$48.45	+$1.23M	32,949
2025-11-12	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−25.5K sh	$66.07	−$1.68M	7,465
2025-11-12	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25.5K sh	—	—	25,484
2025-06-26	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−876 sh	$44.11	−$38.6K	9,007
2025-06-26	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−1,542 sh	$44.01	−$67.9K	7,465
2025-06-26	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−398 sh	$44.13	−$17.6K	2,289
2025-06-26	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−1,891 sh	$44.03	−$83.3K	398
2025-06-20	BBIOBridgeBio Pharma, Inc.A Award	Director	AAward	+6,589 sh	—	—	8,353
2025-06-20	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,425 sh	—	—	8,425
2025-06-18	CDNACareDx, Inc.S Sale	Director	SSale	−10.6K sh	$19.16	−$203K	38,994
2025-06-13	CDNACareDx, Inc.A Award	Director	AAward	+12.1K sh	—	—	49,564
2025-06-10	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,292 sh	$16.75	+$71.9K	6,056
2025-06-10	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−4,292 sh	$40.00	−$172K	1,764
2025-06-10	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,292 sh	—	—	34,334
2025-06-04	PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Stock Option (right to buy)A Award	Director	AAward	+65K sh	—	—	65,000
2025-03-06	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.9K sh	$16.75	+$216K	14,639
2025-03-06	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−12.9K sh	$32.58	−$419K	1,764
2025-03-06	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.9K sh	—	—	38,626
2024-06-21	BBIOBridgeBio Pharma, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,014
2024-06-18	PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.A Award	Director	AAward	+22.8K sh	—	—	22,821
2024-06-18	PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Stock Option (right to buy)A Award	Director	AAward	+32.2K sh	—	—	32,179
2024-06-14	CDNACareDx, Inc.A Award	Director	AAward	+10.6K sh	—	—	37,461
2024-06-14	CDNACareDx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,048
2024-06-14	CDNACareDx, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,048
2024-02-15	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,915 sh	$8.45	+$24.6K	4,679
2024-02-15	BBIOBridgeBio Pharma, Inc.S Sale	Director	SSale	−2,915 sh	$37.75	−$110K	1,764

Recent filings

Accepted (ET)
Jul 174
Valantine Hannah0001855608-26-000004
SEC(opens sec.gov)
Jun 244
Valantine Hannah0001470831-26-000635
SEC(opens sec.gov)
Jun 164
Valantine Hannah0001855608-26-000003
SEC(opens sec.gov)
Jun 44
Valantine Hannah0001299130-26-000102
SEC(opens sec.gov)
Mar 124
Valantine Hannah0001470831-26-000260
SEC(opens sec.gov)

Companies

Address

C/O CAREDX, INC. 8000 MARINA BOULEVARD, 4TH FLOOR

BRISBANE, CA, 94005